Labshake search
Citations for Tocris :
151 - 200 of 546 citations for Killer cell immunoglobulin like receptor 2DL3 KIR2DL3 Human HEK293 His since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2023Quote: ... were dissolved in HEPES-aCSF in the presence of non-NMDA glutamate receptor blockers (CNQX, Tocris, 0190, 40 µM; Nimodipine, Tocris, 0600 ...
-
bioRxiv - Neuroscience 2023Quote: ... sIPSC recordings were performed in voltage clamp mode in the presence of 20 μM AMPA/Kainate receptor antagonist CNQX (Tocris) and 50 μM NMDA receptor antagonist AP5 (Tocris) ...
-
bioRxiv - Developmental Biology 2023Quote: ... The average baseline EPSP was established with a minimum of 20 sweeps before adding glutamate receptor antagonists (10 μM NBQX (Tocris) and 10 μM CPP (Tocris) ...
-
bioRxiv - Neuroscience 2023Quote: ... and 10 μM 6-Imino-3-(4-methoxyphenyl)-1(6H)-pyridazinebutanoic acid hydrobromide (SR95531; GABAA receptor antagonist, all from Tocris). The resting membrane potential was measured after whole-cell configuration was achieved ...
-
bioRxiv - Neuroscience 2024Quote: ... another group of animals received an ip injection of WIN55,212-2 (0.5 mg/kg) along with CB1 receptor antagonist SR141716A (0.5 mg/kg, ip) (Tocris Bioscience, Bristol, UK). Rats were randomly selected for each group ...
-
Sexual differences in neuronal and synaptic properties across subregions of the mouse insular cortexbioRxiv - Neuroscience 2023Quote: ... were recorded at −70 mV and isolated by using the GABAA receptor blocker gabazine 10 mM (SR 95531 hydrobromide; Tocris).
-
bioRxiv - Neuroscience 2023Quote: ... we recorded at −70mV for 48s and for 24s in the presence of the AMPA-receptor antagonist NBQX (3μM) (Tocris Bioscience) diluted in extracellular solution ...
-
bioRxiv - Genomics 2019Quote: ... 20ng/ml human LIF (all from WT-MRC Cambridge Stem Cell Institute) and 2 μM Gö6983 (PKCi; Tocris) on Matrigel–coated plates (Corning) ...
-
bioRxiv - Neuroscience 2021Quote: ... DIV12-13 neurons were pre-treated for 20 minutes with 40 ng/ml of the CXCR2 (CXCL1 receptor in neurons) antagonist SB225002 (Tocris Bioscience), prior to the addition of 40 nM recombinant mouse CXCL1 (R&D Systems ...
-
bioRxiv - Neuroscience 2021Quote: The contribution of activity-dependent incorporation of GluA1 subunit containing AMPA receptors to expression of low repeat t-LTP was verified by postsynaptic application of Pep1-TGL (100 µM, Tocris, Germany) via the patch pipette solution ...
-
bioRxiv - Physiology 2021Quote: ... Picrotoxin (100 µM) was used to block GABAA-receptor-mediated currents and D-2-amino-5-phosphonovalerate (APV; 20 µMm, Tocris Bioscience), and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX ...
-
bioRxiv - Cell Biology 2021Quote: ... B/D medium was supplemented during submerged culture with 1 nM EC23 (light-stable retinoic acid receptor agonist; Tocris, Abingdon, UK). After confluence was reached ...
-
bioRxiv - Cell Biology 2021Quote: ... AMPAR- and NMDAR-EPSC postsynaptic currents were pharmacologically isolated by adding the GABAA receptor blocker picrotoxin (50 μM) (Tocris Cat#1128) to the extracellular bath solution ...
-
bioRxiv - Neuroscience 2023Quote: ... and 10 µM 6-imino-3-(4-methoxyphenyl)-1(6H)-pyridazinebutanoic acid hydrobromide (SR95531;GABAA receptor antagonist; all from Tocris Bioscience).
-
bioRxiv - Neuroscience 2023Quote: ... Experiments were performed at room temperature in oxygenated ACSF containing 50 μM of the GABAA receptor antagonist picrotoxin (Tocris, Ellisville, MO). Recordings from synapses that were silent (failure of transmission at -70 mV ...
-
bioRxiv - Immunology 2023Quote: ... the human Aβ42 peptide (Tocris Bioscience) was dissolved at a concentration of 100 nM in 50 μ𝓁 of 0.1 M sodium bicarbonate coating buffer (pH 8.6) ...
-
bioRxiv - Neuroscience 2021Quote: ... The bath solution usually contained 6,7-dinitroquinoxaline-2,3-dione (DNQX, 10 µM) and D- aminophosphonovaleric acid (D-APV, 50 µM) to block ionotropic glutamate receptors (Tocris, Abingdon, United Kingdom). Patch electrodes had resistances of 4-6 MΩ when filled with KMeSO4- or CMeSO4-based internal solution (same as used in vivo) ...
-
bioRxiv - Neuroscience 2020Quote: ... co-applied with the competitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid AMPA/kainate receptor antagonist CNQX (Tocris; 20 μM) (n=13) ...
-
bioRxiv - Physiology 2020Quote: ... The MOR antagonist CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2, lidocaine, the Ampakine CX614, and the 5-HT4A receptor agonist BIMU8 were obtained from Tocris (ON, Canada).
-
bioRxiv - Neuroscience 2022Quote: ... these experiments were performed in the presence of AMPA and NMDA receptor blockade (10 µM NBQX and 50 µM D-AP5 respectively; Tocris, Bristol, UK). To isolate excitatory currents ...
-
bioRxiv - Neuroscience 2023Quote: ... [Cl-]i measurements were performed by activating either GABAA or glycine receptors by delivering short ‘puffs’ of GABA (Tocris Bioscience, 100 μM) via a patch pipette placed in the vicinity of the cell soma and connected to a picospritzer (5–10 psi for 20– 40 ms ...
-
bioRxiv - Immunology 2019Quote: ... To test the effect of VIP on ILC3, cells were incubated with different concentrations of VIP (human, rat, mouse, rabbit, canine, porcine) from Tocris, Bay 55-9837 (Tocris) ...
-
bioRxiv - Developmental Biology 2021Quote: ... 7 μg/ml human recombinant Insulin (Tocris), 100 ng/ml recombinant human/mouse FGF8b (Tocris ...
-
bioRxiv - Neuroscience 2021Quote: ... were dissolved in magnesium-free HEPES-aCSF in the presence of non-NMDA glutamate receptor blockers (CNQX, Tocris, 0190, 40 μM; Nimodipine, Tocris, 0600, 1 μM; LY-367385, Sigma, L4420, 100 μM; MPEP, Tocris, 1212, 10 μM). Type I mGluR agonist DHPG (Tocris ...
-
bioRxiv - Neuroscience 2021Quote: ... [Cl-]i measurements were performed by activating either GABAA or glycine receptors by delivering short ‘puffs’ of either GABA (Tocris Bioscience, 100 μM) or glycine (Tocris Bioscience ...
-
bioRxiv - Neuroscience 2023Quote: ... were dissolved in HEPES-aCSF in the presence of non-NMDA glutamate receptor blockers (CNQX, Tocris, 0190, 40 µM; Nimodipine, Tocris, 0600, 1 µM; LY-367385, Sigma, L4420, 100 µM; MPEP, Tocris, 1212, 10 µM). Type I mGluR agonist DHPG (Tocris ...
-
bioRxiv - Neuroscience 2024Quote: ... a third group of animals were treated as those in group 2 with the addition of CB1 receptor antagonist AM251 (1 µM) (Tocris Bioscience, Bristol, UK). After 8 DIV ...
-
bioRxiv - Neuroscience 2021Quote: ... was dissolved in HEPES-aCSF in the presence of non-mGluR glutamate receptor blockers (CNQX, Tocris, 0190, 40 μM; Nimodipine, Tocris, 0600, 1 μM; D(-)-2-Amino-5 phosphonopentanoic acid (APV) ...
-
bioRxiv - Neuroscience 2020Quote: ... The bath solution for recordings contained elevated concentrations of divalent cations [4 mM Ca2+ and 4 mM Mg2+] and NMDA receptor antagonist 3-(2-Carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) [5 mM] (Tocris biosciences, 126453-07-4). Slices were used 1.5–4.5 hours after preparation ...
-
bioRxiv - Neuroscience 2019Quote: ... surgeries a single dose (0,6 mg/kg dissolved in phosphate buffer or saline) of P2Y12 receptor (P2Y12R) antagonist (PSB0739 Tocris, R&D Systems, Minneapolis, USA) was administered to the cisterna magna in 5 µl final volume using a glass capillary ...
-
bioRxiv - Neuroscience 2023Quote: ... was dissolved in HEPES-aCSF in the presence of non-mGluR glutamate receptor blockers (CNQX, Tocris, 0190, 40 µM; Nimodipine, Tocris, 0600, 1 µM; D(-)-2-Amino-5 phosphonopentanoic acid (APV) ...
-
bioRxiv - Developmental Biology 2021Quote: ... 100 ng/ml recombinant human/mouse FGF8b (Tocris) between days 1-11 (range tested ...
-
bioRxiv - Neuroscience 2023Quote: ... WT mice were infected with 105 pfu of MA-10 SARS-CoV-2 in the presence of placebo or CGRP-receptor antagonist olcegepant slow-release pellets (olcegepant, BIBN4096, Tocris; 2 mg/kg/day/SQ) or mice lacking CGRP were infected with the same virus ...
-
bioRxiv - Neuroscience 2023Quote: ... WT mice were infected with 105 pfu of MA-10 SARS-CoV-2 in the presence of placebo or CGRP-receptor antagonist olcegepant slow-release pellets (olcegepant, BIBN4096, Tocris; 2 mg/kg/day/SQ) or mice lacking CGRP were infected with the same virus ...
-
bioRxiv - Neuroscience 2021Quote: ... glutamate and GABA receptor blockers (10 μM NBQX, Tocris, UK, 1044; 5 μM CPP, Tocris, 0247; 5 μM SR-95531, Tocris, 1262; 1 μM CGP-55845, Tocris, 1248) were included in the recording solutions.
-
bioRxiv - Immunology 2020Quote: ... Sigma Aldrich] 30 min prior to activation followed by treatment with 5μg/mL anti-IgM and 1,25μg/mL CpG or were first activated with anti-IgM/CpG for 4h followed by incubation with indicated concentrations of α- or ß-adrenergic receptor (ADR) agonists (ADRA1: (R)-(-)-Phenylephrine hydrochloride (Tocris, Bristol, UK, catalogue number: 2838), ADRA2 ...
-
bioRxiv - Neuroscience 2021Quote: ... at which point 50nM CRF (human/rat, Cat. No 1151, Tocris) was added to the bath ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: Lyophilized and HPLC-purified Human β-Amyloid1-42 (Aβ1-42) peptide was purchased from Tocris (#1428). 1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP ...
-
bioRxiv - Immunology 2023Quote: ... The scFv library was subjected to four rounds of bio-panning against the human Aβ42 peptide (Tocris Bioscience Amyloid β-Peptide 1-42 human ...
-
bioRxiv - Physiology 2024Quote: Overnight recovered mouse or human islets were cultured with 0.1% DMSO (vehicle) or 9 µM AGK2 (Tocris), 25 µM AK-1 (EMD-Millipore) ...
-
bioRxiv - Cancer Biology 2024Quote: ... Human Organoid Growth Medium (HOGM): 50 µl of HOGM consisted of 25 µl A83-01 (1mM, Tocris), 50 µl Human Epidermal Growth Factor (hEGF ...
-
bioRxiv - Cell Biology 2023Quote: ... 10 nM gastrin, 100 ng/ml recombinant human NRG1 (RD, 5898-NR) and 500 nM A83-01 (Tocris). Human mini-colons were maintained for 14 and 21 days ...
-
bioRxiv - Bioengineering 2023Quote: ... 10 nM gastrin, 50 ng/ml recombinant human EGF (R&D, 236-EG) and 500 nM A83-01 (Tocris). Organoids were passaged every 4 days by physical dissociation using fire-polished Pasteur pipettes.
-
bioRxiv - Pathology 2020Quote: ... undifferentiated cells were seeded at 1,000 cells/cm2 in mTeSR1 supplemented with 10 μM Y-27632 (Tocris) on Matrigel-coated dishes ...
-
bioRxiv - Developmental Biology 2021Quote: ... cells were treated with BAY-826 (TOCRIS) at a final concentration of 1.3 nM for 1-3 days during sprouting.
-
bioRxiv - Cancer Biology 2022Quote: ... we treated cells ATN-161 (Tocris, #6058) for 24 hours using concentrations indicated in the figures.
-
bioRxiv - Systems Biology 2022Quote: ... cells were treated with Pladienolide B (Tocris) 24 hours prior to irradiation ...
-
bioRxiv - Immunology 2023Quote: ... cells were treated with 10μM ML120B (Tocris) for 30 min ...
-
bioRxiv - Immunology 2023Quote: ... pretreatment of cells with ML120B (Tocris, 10uM)57 was performed for 3h before addition of other reagents ...
-
bioRxiv - Cancer Biology 2023Quote: ... cells were treated with MG-132 (Tocris) 10 µM for 90 min at 37°C ...